Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,218 | 74,386 | 91,339 | 57,263 | 58,853 |
| Receivables | 18,125 | 16,202 | 18,334 | 10,402 | 10,845 |
| Inventories | 11,818 | 12,852 | 12,496 | 14,431 | 11,788 |
| Other current assets | 0 | 0 | 0 | 1,165 | 2,209 |
| TOTAL | $118,503 | $110,396 | $126,903 | $90,371 | $86,278 |
| Non-Current Assets | |||||
| PPE Net | 2,611 | 2,704 | 2,796 | 3,260 | 3,403 |
| Intangibles | 28,670 | 29,734 | 30,798 | 31,863 | 17,844 |
| Other Non-Current Assets | 31,623 | 17,061 | 17,574 | 18,729 | 19,560 |
| TOTAL | $62,904 | $49,499 | $51,168 | $53,852 | $40,807 |
| Total Assets | $181,407 | $159,895 | $178,071 | $144,223 | $127,085 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,750 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 45,171 | 48,576 | 66,286 | 65,501 | 64,499 |
| Other current liabilities | 137 | 2,071 | 2,402 | 2,343 | 1,192 |
| TOTAL | $54,067 | $57,521 | $73,674 | $71,399 | $70,305 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,774 | 50,026 | 56,382 | 57,962 | 52,473 |
| Other Non-Current Liabilities | 11,404 | 42,105 | 29,636 | 36,055 | 30,872 |
| TOTAL | $62,155 | $64,991 | $71,911 | $74,468 | $69,518 |
| Total Liabilities | $116,222 | $122,512 | $145,585 | $145,867 | $139,823 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,038 | 29,755 | 29,570 | 29,534 | 27,605 |
| Common Shares | 31 | 30 | 30 | 28 | 28 |
| Retained earnings | -730,115 | -735,965 | -751,451 | -740,867 | -734,102 |
| Other shareholders' equity | 9,323 | -6,541 | 10,236 | -24,381 | -33,896 |
| TOTAL | $65,185 | $37,383 | $32,486 | $-1,644 | $-12,738 |
| Total Liabilities And Equity | $181,407 | $159,895 | $178,071 | $144,223 | $127,085 |